Aarey Drugs & Pharmaceuticals Ltd (AAREYDRUGS) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 933527, "name": "Aarey Drugs", "stock_name": "Aarey Drugs", "full_name": "Aarey Drugs & Pharmaceuticals Ltd", "name_url": "stocks-analysis/aarey-drugs", "exchange": 0, "exchangecode": "", "country_id": 34, "currency": "INR", "cmp": "67.46", "chg": 1.43, "chgp": "2.17%", "dir": 1, "prev_price": "66.03", "mcapval": "183.00 Cr", "mcap": "Micro Cap", "scripcode": 524412, "symbol": "AAREYDRUGS", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 49, "indexname": "", "isin": "INE198H01019", "curr_date": "Feb 06", "curr_time": "", "bse_nse_vol": "1.14 lacs", "exc_status": "Active", "traded_date": "Feb 06, 2026", "traded_date_str": "2026 02 06", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/aarey-drugs-933527-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Aarey Drugs Declines 3.16% Amid Lower Circuit and Death Cross Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/aarey-drugs-declines-316-amid-lower-circuit-and-death-cross-signals-3826219", "imagepath": "", "date": "2026-02-07 14:04:18", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>2 Feb:</strong> Stock hits lower circuit at Rs.61.08 (-4.99%) amid panic selling</p>\n <p><strong>3 Feb:</strong> Partial recovery with a 2.75% gain to Rs.64.91</p>\n <p><strong>6 Feb:</strong> Death Cross formation signals bearish trend</p>\n <p><strong>6 Feb:</strong> Week closes at Rs.67.19, down 3.16% for the week</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.69.38</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.67.19</div..." }, { "title": "Aarey Drugs & Pharmaceuticals Ltd Forms Death Cross, Signalling Bearish Trend", "link": "https://www.marketsmojo.com/news/stocks-in-action/aarey-drugs-pharmaceuticals-ltd-forms-death-cross-signalling-bearish-trend-3824725", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AareyDrugsPharm_dealthcross_3824725.png", "date": "2026-02-06 18:00:21", "description": "Aarey Drugs & Pharmaceuticals Ltd has recently formed a Death Cross, a significant technical indicator where the 50-day moving average (DMA) crosses below the 200-DMA. This development signals a potential shift towards a bearish trend, reflecting deteriorating momentum and raising concerns about the stock's medium to long-term outlook within the Pharmaceuticals & Biotechnology sector." }, { "title": "When is the next results date for Aarey Drugs & Pharmaceuticals Ltd?", "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-aarey-drugs-pharmaceuticals-ltd-3823248", "imagepath": "", "date": "2026-02-05 23:18:31", "description": "The next results date for Aarey Drugs & Pharmaceuticals Ltd is scheduled for 11 February 2026...." }, { "title": "Aarey Drugs & Pharmaceuticals Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/aarey-drugs-pharmaceuticals-ltd-is-rated-strong-sell-3822161", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AareyDrugsPharm_mojoScore_3822161.png", "date": "2026-02-05 10:10:57", "description": "Aarey Drugs & Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 28 Nov 2025, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 05 February 2026, providing investors with the latest comprehensive view of the company’s position." }, { "title": "Aarey Drugs & Pharmaceuticals Ltd Hits Lower Circuit Amid Heavy Selling Pressure", "link": "https://www.marketsmojo.com/news/stocks-in-action/aarey-drugs-pharmaceuticals-ltd-hits-lower-circuit-amid-heavy-selling-pressure-3816566", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AareyDrugsPharm_stocks_hitting_lower_circuit_3816566.png", "date": "2026-02-02 12:00:19", "description": "Shares of Aarey Drugs & Pharmaceuticals Ltd plunged to their lower circuit limit on 2 Feb 2026, closing at ₹61.08, marking a maximum daily loss of 4.99%. The stock witnessed intense selling pressure, with volumes concentrated near the day’s low, signalling panic selling and a sharp decline in investor confidence amid deteriorating fundamentals and weak market sentiment." }, { "title": "Aarey Drugs & Pharmaceuticals Ltd Hits Lower Circuit Amid Heavy Selling Pressure", "link": "https://www.marketsmojo.com/news/stocks-in-action/aarey-drugs-pharmaceuticals-ltd-hits-lower-circuit-amid-heavy-selling-pressure-3814737", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AareyDrugsPharm_stocks_hitting_lower_circuit_3814737.png", "date": "2026-02-01 14:00:11", "description": "Shares of Aarey Drugs & Pharmaceuticals Ltd plunged to their lower circuit limit on 1 Feb 2026, succumbing to intense selling pressure that saw the stock lose nearly 5% in a single session. The micro-cap pharmaceutical company’s stock performance has deteriorated sharply, reflecting mounting investor concerns and a sustained downtrend that has wiped out over 8% in the past two days." }, { "title": "Aarey Drugs & Pharmaceuticals Ltd Hits Upper Circuit Amid Strong Buying Pressure", "link": "https://www.marketsmojo.com/news/stocks-in-action/aarey-drugs-pharmaceuticals-ltd-hits-upper-circuit-amid-strong-buying-pressure-3807920", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AareyDrugsPharm_stocks_hitting_upper_circuit_3807920.png", "date": "2026-01-28 15:00:10", "description": "Aarey Drugs & Pharmaceuticals Ltd witnessed a robust surge in its share price on 28 Jan 2026, hitting the upper circuit limit of 4.99% to close at ₹71.30. This significant price movement was driven by intense buying interest, resulting in a trading halt due to regulatory freeze mechanisms. The stock outperformed its sector and broader market indices, reflecting renewed investor enthusiasm despite its current Strong Sell rating." }, { "title": "Aarey Drugs & Pharmaceuticals Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/aarey-drugs-pharmaceuticals-ltd-is-rated-strong-sell-3803957", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AareyDrugsPharm_mojoScore_3803957.png", "date": "2026-01-25 10:10:42", "description": "Aarey Drugs & Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 Nov 2025. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the company’s current position as of 25 January 2026, providing investors with the latest insights into the stock’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Why is Aarey Drugs & Pharmaceuticals Ltd falling/rising?", "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-aarey-drugs-pharmaceuticals-ltd-fallingrising-3802752", "imagepath": "", "date": "2026-01-24 00:58:10", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Strong Relative Performance Against Benchmarks</strong></p>\n<p>The stock’s upward movement on 23-Jan is part of a broader trend of outperformance. Over the past week, Aarey Drugs & Pharmaceuticals Ltd has gained 7.05%, significantly surpassing the Sensex’s decline of 2.43% during the same period. This divergence highlights the stock’s resilience amid a generally bearish market environment. Year-to-date, the stock has appreciated by 1.68%, while the Sensex has fallen by 4.32%, further emphasising its relative strength.</p>\n<p>Looking at longer-term returns, the stock has delivered impressive gains of 36.28% over the last year, compared to the Sensex’s 6.56%. Over three and five years, the stock’s cumulative returns stand at 84.75% and 152.09% respectively, more than doubling the benchmark..." } ], "total": 557, "sid": "933527", "stock_news_url": "https://www.marketsmojo.com/news/aarey-drugs-pharmaceuticals-933527" }, "announcements": [ { "caption": "Board Meeting Intimation for Board Meeting Intimation", "datetime": "04-Feb-2026", "details": "Aarey Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 inter alia to consider and approve This is to intimate that the meeting of the Board of Directors of the Company is scheduled to be held on Wednesday11th February 2026 to transact the following business: 1. To consider and approve the Unaudited Financial Result along with Limited review Report for the quarter ended 31st December 2025.", "source": "BSE" }, { "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018", "datetime": "14-Jan-2026", "details": "Certificate under reg 74(5) of SEBI (Depositories and Participants) Regulations 2018", "source": "BSE" }, { "caption": "Closure of Trading Window", "datetime": "30-Dec-2025", "details": "Intimation for Closure of Trading Window", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "", "data": [ { "title": "BOARD MEETING", "txt": "11 Feb 2026" } ] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Aarey Drugs & Pharmaceuticals Ltd has declared <strong>1%</strong> dividend, ex-date: 13 Dec 18", "dt": "2018-12-13", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "", "data": [ { "txt": "Aarey Drugs & Pharmaceuticals Ltd has announced <strong>1:5</strong> bonus issue, ex-date: 25 Jun 12", "dt": "2012-06-25", "middle_text": "Bonus Alert" } ] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "", "data": [ { "txt": "Aarey Drugs & Pharmaceuticals Ltd has announced <strong>2:1</strong> rights issue, ex-date: 19 Jan 12", "dt": "2012-01-19", "middle_text": "Rights Issue" } ] } ] }

Key Events This Week

2 Feb: Stock hits lower circuit at Rs.61.08 (-4.99%) amid panic selling

3 Feb: Partial recovery with a 2.75% gain to Rs.64.91

6 Feb: Death Cross formation signals bearish trend

6 Feb: Week closes at Rs.67.19, down 3.16% for the week

Week Open

Rs.69.38

Week Close

Rs.67.19Read full news article

Aarey Drugs & Pharmaceuticals Ltd Forms Death Cross, Signalling Bearish Trend

2026-02-06 18:00:21

Aarey Drugs & Pharmaceuticals Ltd has recently formed a Death Cross, a significant technical indicator where the 50-day moving average (DMA) crosses below the 200-DMA. This development signals a potential shift towards a bearish trend, reflecting deteriorating momentum and raising concerns about the stock's medium to long-term outlook within the Pharmaceuticals & Biotechnology sector.

Read full news article

When is the next results date for Aarey Drugs & Pharmaceuticals Ltd?

2026-02-05 23:18:31

The next results date for Aarey Drugs & Pharmaceuticals Ltd is scheduled for 11 February 2026....

Read full news article

Aarey Drugs & Pharmaceuticals Ltd is Rated Strong Sell

2026-02-05 10:10:57

Aarey Drugs & Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 28 Nov 2025, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 05 February 2026, providing investors with the latest comprehensive view of the company’s position.

Read full news article

Aarey Drugs & Pharmaceuticals Ltd Hits Lower Circuit Amid Heavy Selling Pressure

2026-02-02 12:00:19

Shares of Aarey Drugs & Pharmaceuticals Ltd plunged to their lower circuit limit on 2 Feb 2026, closing at ₹61.08, marking a maximum daily loss of 4.99%. The stock witnessed intense selling pressure, with volumes concentrated near the day’s low, signalling panic selling and a sharp decline in investor confidence amid deteriorating fundamentals and weak market sentiment.

Read full news article

Aarey Drugs & Pharmaceuticals Ltd Hits Lower Circuit Amid Heavy Selling Pressure

2026-02-01 14:00:11

Shares of Aarey Drugs & Pharmaceuticals Ltd plunged to their lower circuit limit on 1 Feb 2026, succumbing to intense selling pressure that saw the stock lose nearly 5% in a single session. The micro-cap pharmaceutical company’s stock performance has deteriorated sharply, reflecting mounting investor concerns and a sustained downtrend that has wiped out over 8% in the past two days.

Read full news article

Aarey Drugs & Pharmaceuticals Ltd Hits Upper Circuit Amid Strong Buying Pressure

2026-01-28 15:00:10

Aarey Drugs & Pharmaceuticals Ltd witnessed a robust surge in its share price on 28 Jan 2026, hitting the upper circuit limit of 4.99% to close at ₹71.30. This significant price movement was driven by intense buying interest, resulting in a trading halt due to regulatory freeze mechanisms. The stock outperformed its sector and broader market indices, reflecting renewed investor enthusiasm despite its current Strong Sell rating.

Read full news article

Aarey Drugs & Pharmaceuticals Ltd is Rated Strong Sell

2026-01-25 10:10:42

Aarey Drugs & Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 Nov 2025. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the company’s current position as of 25 January 2026, providing investors with the latest insights into the stock’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Why is Aarey Drugs & Pharmaceuticals Ltd falling/rising?

2026-01-24 00:58:10

Strong Relative Performance Against Benchmarks

The stock’s upward movement on 23-Jan is part of a broader trend of outperformance. Over the past week, Aarey Drugs & Pharmaceuticals Ltd has gained 7.05%, significantly surpassing the Sensex’s decline of 2.43% during the same period. This divergence highlights the stock’s resilience amid a generally bearish market environment. Year-to-date, the stock has appreciated by 1.68%, while the Sensex has fallen by 4.32%, further emphasising its relative strength.

Looking at longer-term returns, the stock has delivered impressive gains of 36.28% over the last year, compared to the Sensex’s 6.56%. Over three and five years, the stock’s cumulative returns stand at 84.75% and 152.09% respectively, more than doubling the benchmark...

Read full news article

View All News